These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31207077)

  • 1. Impact of patient comfort on diagnostic image quality during PET/MR exam: A quantitative survey study for clinical workflow management.
    Chen S; Hu P; Gu Y; Pang L; Zhang Z; Zhang Y; Meng X; Cao T; Liu X; Fan Z; Shi H
    J Appl Clin Med Phys; 2019 Jul; 20(7):184-192. PubMed ID: 31207077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and performance evaluation of simultaneous PET/MR whole-body imaging with continuous table motion.
    Braun H; Ziegler S; Lentschig MG; Quick HH
    J Nucl Med; 2014 Jan; 55(1):161-8. PubMed ID: 24232869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved clinical workflow for simultaneous whole-body PET/MRI using high-resolution CAIPIRINHA-accelerated MR-based attenuation correction.
    Freitag MT; Fenchel M; Bäumer P; Heußer T; Rank CM; Kachelrieß M; Paech D; Kopka K; Bickelhaupt S; Dimitrakopoulou-Strauss A; Maier-Hein K; Floca R; Ladd ME; Schlemmer HP; Maier F
    Eur J Radiol; 2017 Nov; 96():12-20. PubMed ID: 29103469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient comfort during positron emission tomography/magnetic resonance and positron emission tomography/computed tomography examinations: subjective assessments with visual analog scales.
    Gückel B; Gatidis S; Enck P; Schäfer J; Bisdas S; Pfannenberg C; Schwenzer N
    Invest Radiol; 2015 Oct; 50(10):726-32. PubMed ID: 26039772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice.
    Al-Nabhani KZ; Syed R; Michopoulou S; Alkalbani J; Afaq A; Panagiotidis E; O'Meara C; Groves A; Ell P; Bomanji J
    J Nucl Med; 2014 Jan; 55(1):88-94. PubMed ID: 24337608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and qualitative evaluation of sequential PET/MRI using a newly developed mobile PET system for brain imaging.
    Suzuki M; Fushimi Y; Okada T; Hinoda T; Nakamoto R; Arakawa Y; Sawamoto N; Togashi K; Nakamoto Y
    Jpn J Radiol; 2021 Jul; 39(7):669-680. PubMed ID: 33641056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical issues regarding misclassification by Dixon based PET/MR attenuation correction.
    Kong E; Cho I
    Hell J Nucl Med; 2015; 18(1):42-7. PubMed ID: 25840572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative value of three whole-body MR approaches for PET-MR, including gadofosveset-enhanced MR, in comparison to PET-CT.
    Obara P; Loening A; Taviani V; Iagaru A; Hargreaves BA; Vasanawala S
    Clin Imaging; 2018; 48():62-68. PubMed ID: 29031209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, crossover comparison of novel continuous bed motion versus traditional bed position whole-body PET/CT imaging.
    Schatka I; Weiberg D; Reichelt S; Owsianski-Hille N; Derlin T; Berding G; Bengel FM
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):711-7. PubMed ID: 26546010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET attenuation correction using synthetic CT from ultrashort echo-time MR imaging.
    Roy S; Wang WT; Carass A; Prince JL; Butman JA; Pham DL
    J Nucl Med; 2014 Dec; 55(12):2071-7. PubMed ID: 25413135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging.
    Aznar MC; Sersar R; Saabye J; Ladefoged CN; Andersen FL; Rasmussen JH; Löfgren J; Beyer T
    Eur J Radiol; 2014 Jul; 83(7):1177-1183. PubMed ID: 24780817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of time-of-flight PET on quantification errors in MR imaging-based attenuation correction.
    Mehranian A; Zaidi H
    J Nucl Med; 2015 Apr; 56(4):635-41. PubMed ID: 25745090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors.
    Shih IL; Yen RF; Chen CA; Chen BB; Wei SY; Chang WC; Sheu BC; Cheng WF; Tseng YH; Chen XJ; Chen CH; Wei LH; Chiang YC; Torng PL; Yen ML; Shih TT
    J Magn Reson Imaging; 2015 Dec; 42(6):1723-32. PubMed ID: 25919115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear cause.
    Rauscher I; Beer AJ; Schaeffeler C; Souvatzoglou M; Crönlein M; Kirchhoff C; Sandmann G; Fürst S; Kilger R; Herz M; Ziegler S; Schwaiger M; Eiber M
    J Nucl Med; 2015 Mar; 56(3):430-5. PubMed ID: 25678485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
    Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
    J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.